CIK 0001802768
- Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +1 212-883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- 4 Grant or award Director acquired 1,384 shares (grant or award)
- 4 Grant or award Director acquired 1,384 shares (grant or award)
- 4 Planned sale EVP & CFO sold 75,000 shares at an average $30.73 ($2,305,028)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP & CFO sold 75,000 shares at an average $31.00 ($2,325,214)
- 4 Grant or award Director acquired 1,208 shares (grant or award)
- 4 Grant or award Director acquired 1,208 shares (grant or award)
- 4 Open-market buy CEO, Chairman of the Board bought 130,000 shares at $29.51 ($3,836,768)
- 4 Grant or award Director acquired 7,747 shares (grant or award)
- 4 Grant or award Director acquired 7,747 shares (grant or award)
- 4 Grant or award Director acquired 7,747 shares (grant or award)
- 4 Grant or award Director acquired 7,747 shares (grant or award)
- 4 Grant or award Director acquired 7,747 shares (grant or award)
- 4 Grant or award Director acquired 7,747 shares (grant or award)
- 4 Grant or award Director acquired 7,747 shares (grant or award)
- 4 Grant or award Director acquired 7,747 shares (grant or award)
- 4 Grant or award Director acquired 7,747 shares (grant or award)
- 4 Open-market buy CEO, Chairman of the Board bought 90,000 shares at an average $32.89 ($2,959,848)
Page 8 of 18 · 342 filings